Document is current

Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1007/s00296-016-3621-1

Published Online: 2016-12-23

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy